| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 01/08/2008 | CA2225830C Dialkyl phenyl halide-substituted keto-enols for use as herbicides and pesticides |
| 01/03/2008 | WO2008001859A1 OPIOID δ RECEPTOR AGONIST |
| 01/03/2008 | WO2008001134A1 1,2,3,8,9,9a-hexahydro-7h-benzo(de)-1,7-naphthyridin-7-one derivatives as inhibitors of poly(adp-ribose) polymerase (parp) |
| 01/03/2008 | WO2008000951A2 Urea derivatives of tropane, their preparation and their therapeutic application |
| 01/03/2008 | WO2008000646A1 Long wavelength shifted benzotriazole uv-absorbers and their use |
| 01/03/2008 | WO2008000483A2 Phenol derivatives for the treatment of respiratory diseases |
| 01/03/2008 | WO2008000469A2 Nicotinic agonists selective for the alpha7 receptor subtype, the process for the preparation thereof and pharmaceutical compositions therefrom |
| 01/03/2008 | WO2007122341A3 Specific monocationic monochromophoric hydrazone compounds containing a 2-(benz)imidazolium unit, their synthesis, dyeing compositions comprising them, method of dyeing keratin fibres |
| 01/03/2008 | WO2007066201A3 Chemical compounds |
| 01/03/2008 | WO2006104915A9 8-PHENYL-7,8-DIHYDROPYRIDO[2,3-d]PYRIMIDIN-7-ONES AND THEIR USE AS PHARMACEUTICALS |
| 01/03/2008 | US20080004309 [(2-bromo-4-hydroxy-1-phenyl-1H-pyrrolo[2,3-c]pyridine-5-carbonyl)-amino]-acetic acid; modulates the stability and/or activity of hypoxia inducible factor (HIF) |
| 01/03/2008 | US20080004308 Azaindole inhibitors of aurora kinases |
| 01/03/2008 | US20080004307 Azaindoles Having Serotonin Receptor Affinity |
| 01/03/2008 | US20080004306 Compositions and methods for modulating gated ion channels |
| 01/03/2008 | US20080004294 Heterocyclic compounds |
| 01/03/2008 | US20080004285 Pyrido(3,2-d)pyrimidines and pharmaceutical compositions useful for medical treatment |
| 01/03/2008 | US20080004270 3,4-Disubstituted Pyrazoles as Cyclin Dependent Kinases (Cdk) or Aurora Kinase or Glycogen Synthase 3 (Gsk-3) Inhibitors |
| 01/03/2008 | US20080004250 Use of potent antiandrogen compounds with lower androgenic activities, such as 3 beta -acetoxyandrost-1,5-diene-17-ethylene ketal (ADEK) and 3 beta -hydroxyandrost-1,5-diene-17-ethylene ketal; androgen-independent prostate cancer |
| 01/03/2008 | CA2654650A1 Organic compounds |
| 01/03/2008 | CA2648769A1 Urea derivatives of tropane, their preparation and their therapeutic application |
| 01/02/2008 | EP1873155A1 Inhibitors of the HIV integrase enzyme |
| 01/02/2008 | EP1873154A1 PYRAZOLO[1,5-a]PYRIDINE DERIVATIVE OR MEDICALLY ACCEPTABLE SALT THEREOF |
| 01/02/2008 | EP1871773A1 N-[3-(1-amino-5,6,7,8-tetrahydro-2,4,4b-triazafluoren-9-yl)-phenyl]benzamides as tyrosine/threonine kinase inhibitors, in particular b-raf kinase |
| 01/02/2008 | EP1871377A1 2,4-diamino-pyridopyrimidine derivatives and their use as mtor inhibitors |
| 01/02/2008 | EP1871376A2 Inhibitors of akt activity |
| 01/02/2008 | EP1519936B1 Method of making nevirapine |
| 01/02/2008 | EP1416933B1 Substituted piperidines as modulators of the melanocortin receptor |
| 01/02/2008 | EP1414797B1 Hepatitis c virus polymerase inhibitors with a heterobicylic structure |
| 01/02/2008 | EP1414441B1 Hepatitis c virus polymerase inhibitors with heterobicyclic structure |
| 01/02/2008 | EP1335915B1 Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents) |
| 01/02/2008 | EP1124828B1 Pyrano, piperidino, and thiopyrano compounds and methods of use |
| 01/02/2008 | CN101098871A Novel spirotropane compounds and methods for the modulation of chemokine receptor activity |
| 01/02/2008 | CN101098870A Novel fused imidazole derivative |
| 01/02/2008 | CN101098856A Lactam compounds and their use as pharmaceuticals |
| 01/02/2008 | CN101098699A Chromane derivatives useful as acid pump antagonists |
| 01/02/2008 | CN100358949C Oxidation process for preparing quinacridone pigments |
| 01/02/2008 | CN100358894C Process for complete synthesizing quinamide of diji frog of high antimer pure nutural |
| 01/02/2008 | CN100358893C Use of and some novel imidazopyridines |
| 01/02/2008 | CN100358892C 7-oxo pyridopyrimidines |
| 01/02/2008 | CN100358888C Novel guanidine mimics as factor Xa inhibitors |
| 01/01/2008 | US7314940 For therapy and prophylaxis of neurodegenerative disorders related to apoptosis and/or inflammation |
| 01/01/2008 | US7314937 Non-imidazole aryl alkylamines compounds as histamine H3 receptor antagonists, preparation and therapeutic uses |
| 01/01/2008 | US7314936 antiinflammatory agents; 1H-imidazo[4,5-b]pyridin-7-indole-2-yl- derivatives; autoimmune and proliferative disorders; inhibitors of cell adhesion molecule expression and inflammatory cytokine signal transduction; rheumatoid arthritis, ulcerative colitis/Crohn's disease, central nervous system diseases |
| 01/01/2008 | US7314935 Optically pure dihydroimidazo[1,2-h][1,7]naphthyridine intermediates for tetrahydroimidazo[1,2-h][1,7]naphthyridine gastrointestinal antisecretory agents; 7-Acetoxy-10-acetyl-2,3-dimethyl-9-phenyl-9,10-dihydroimidazo[1,2-h][1,7]naphthyridine |
| 01/01/2008 | US7314934 Substituted 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds, e.g., 8-(2,6-Difluoro-phenyl)-4-(4-fluoro-2-methyl-phenyl)-2-(2-hydroxy-1-hydroxymethyl-ethylamino)-8H-pyrido[2,3-d]pyrimidin-7-one; CSBP/p38 kinase inhibitors |
| 01/01/2008 | US7314884 non-insulin dependent diabetes mellitus, and impaired glucose tolerance; dipeptidyl peptidase IV (DPP-IV) inhibitors eg (2S)-1-{[(1S)-2-(5-cyano-2-methyl-indol-1-yl)-1-methyl-ethylamino]-acetyl}-pyrrolidine-2-carbonitrile |
| 01/01/2008 | US7314883 (+-)-3-(1H-Indazol-5-yl)-2-{[4-(2-oxo-1,4-dihydro-2H-quinazolin-3-yl)-piperidine-1-carbonyl]-amino}-propionic acid to treat neurogenic vasodilation, neurogenic inflammaton, thermal injury, circulatory shock, flushing associated with menopause, airway inflammatory diseases |
| 01/01/2008 | US7314882 Benzyl 2-oxo-6-phenyl-1,2,3,4-tetrahydro-1,5-naphthyridin-3-ylcarbamate; CB-1 antagonist; regulating appetitive behavior |
| 01/01/2008 | US7314881 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds |
| 01/01/2008 | US7314876 Administering to mammals nitrogen compounds, as mitogen activated kinase inhibitors, for prophylaxis asthma, respiratory system disorders, graft versus host disease, atherosclerosis and arthritis |
| 01/01/2008 | US7314873 (Halo-benzo carbonyl)heterobi cyclic p38 linase inhibiting agents |
| 01/01/2008 | US7314870 Compounds, their preparation and use |
| 12/27/2007 | WO2007149451A2 Cycloalkanopyrrolocarbazole derivatives and the use thereof as parp, vegfr2 and mlk3 inhibitors |
| 12/27/2007 | WO2007148755A1 Novel compound having affinity for amyloid |
| 12/27/2007 | WO2007148738A1 Pest control agent containing novel pyridyl-methanamine derivative or salt thereof |
| 12/27/2007 | WO2007148185A2 Substituted 3 -amino- pyrrolidino-4 -lactams as dpp inhibitors |
| 12/27/2007 | WO2007148137A1 Novel hydrate form of moxifloxacin monohydrochloride |
| 12/27/2007 | WO2007147874A1 Pyridine and pyrazine derivatives as mnk kinase inhibitors |
| 12/27/2007 | WO2007147794A1 Furan derivatives and their use as antiviral agents |
| 12/27/2007 | WO2007147478A1 3 -amino-imidazo[1, 2-a]pyridine derivatives as sglt inhibitors |
| 12/27/2007 | WO2007147346A1 Quaternary ammonium salt compounds of spirocyclopiperazines, preparation methods and uses thereof |
| 12/27/2007 | WO2007125321A3 Purine and deazapurine derivatives as pharmaceutical compounds |
| 12/27/2007 | WO2007125315A3 Pharmaceutical compounds |
| 12/27/2007 | WO2007109812A3 Immunopotentiating compounds |
| 12/27/2007 | WO2007072158A3 Pyrimidine derivatives for the treatment of abnormal cell growth |
| 12/27/2007 | WO2007064914A3 5-(arylsulfonyl)-pyrazolopiperidines |
| 12/27/2007 | US20070299261 Oxidizing a (pyridinylmethyl]thioimidazo[4,5-b]pyridine derivative using titanium(IV)-based catalyst and a cyclic beta- or gamma-amino-alcohol chiral ligand (1-amino-2-indanol) in a polar aprotic solvent to form a (pyridinylmethyl]sulfinylimidazo[4,5-b]pyridine derative such as tenatoprazole |
| 12/27/2007 | US20070299108 New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents |
| 12/27/2007 | US20070299104 Tetrahydropyranyl Cyclopentyl 1-Substituted and 1,1-Disubstituted Tetrahydroisoquinoline Modulators of Chemokine Receptor Activity |
| 12/27/2007 | US20070299103 [1,2,4]Triazolo[4,3-A]Pyridine Derivatives for the Treatment of Hyperproliferative Diseases |
| 12/27/2007 | US20070299102 Diphenyl Ox-Indol-2-One Compounds and Their Use in the Treatment of Cancer |
| 12/27/2007 | US20070299101 Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment |
| 12/27/2007 | US20070299091 Azaindole Carboxamides |
| 12/27/2007 | US20070299079 4-AMINO-PYRIDO[3,2-e]PYRAZINES, THEIR USE AS INHIBITORS OF PHOSPHODIESTERASE 10, AND PROCESSES FOR PREPARING THEM |
| 12/27/2007 | US20070299073 Imidazolyl derivatives |
| 12/27/2007 | US20070299072 Kv1.5 potassium channel inhibitors |
| 12/27/2007 | US20070299058 Anxiolytic Agents With Reduced Sedative And Ataxic Effects |
| 12/27/2007 | US20070299056 Benzazepine derivatives for the treatment of neurological disorders |
| 12/27/2007 | US20070298962 Catalysts and methods for catalytic oxidation |
| 12/27/2007 | DE102006028862A1 3-Amino-imidazo[1,2-a]pyridinderivate 3-amino-imidazo [1,2-a] pyridine |
| 12/27/2007 | DE102006020327A1 Heterocyclisch substituierte, anellierte Pyrazol-Derivate und ihre Verwendung Heterocyclic-substituted, fused pyrazole derivatives and their use |
| 12/27/2007 | CA2656711A1 Novel hydrate form of moxifloxacin monohydrochloride |
| 12/27/2007 | CA2655826A1 Novel compound having affinity for amyloid |
| 12/27/2007 | CA2655780A1 3-aminoimidazo [1,2-a] pyridine derivatives as sglt inhibitors |
| 12/27/2007 | CA2655014A1 Cycloalkanopyrrolocarbazole derivatives and the use thereof as parp, vegfr2 and mlk3 inhibitors |
| 12/27/2007 | CA2654358A1 Pyridine and pyrazine derivatives as mnk kinase inhibitors |
| 12/27/2007 | CA2654262A1 Kv1.5 potassium channel inhibitors |
| 12/26/2007 | EP1870414A1 Thienopyridine derivative, or quinoline derivative, or quinazoline derivative, having c-met autophosphorylation inhibiting potency |
| 12/26/2007 | EP1870410A1 Substituted arylpyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
| 12/26/2007 | EP1870399A1 Hydroxamate derivatives useful as deacetylase inhibitors |
| 12/26/2007 | EP1869060A1 Selective glycosidase inhibitors, methods of making inhibitors, and uses thereof |
| 12/26/2007 | EP1869046A1 Novel diazaspiroalkanes and their use for treatment of ccr8 mediated diseases |
| 12/26/2007 | EP1869045A1 Novel diazaspiroalkanes and their use for treatment of ccr8 mediated diseases |
| 12/26/2007 | EP1869044A1 Novel diazaspiroalkanes and their use for treatment of ccr8 mediated diseases |
| 12/26/2007 | EP1869043A2 Pyrazolopyridine-1,4-diamines and analogs thereof |
| 12/26/2007 | EP1869042A2 Novel isoindole derivatives, compositions containing same, preparation thereof and pharmaceutical uses thereof in particular as inhibitors of chaperone protein hsp90 activities |
| 12/26/2007 | EP1869041A1 Tetrahydro-pyridoazepin-8-ones and related compounds for the treatment of schizophrenia |
| 12/26/2007 | EP1869040A1 Dna-pk inhibitors |
| 12/26/2007 | EP1869039A2 Process for preparing bicyclic compounds |
| 12/26/2007 | EP1869038A1 Substituted 5,6,7,8-tetrahydro-imidazoý1,2-a¨pyridin-2-ylamine compounds and their use for producing drugs |